NCT01839240 2020-05-15Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid LeukemiaUniversity of ChicagoPhase 1 Completed50 enrolled
NCT01260714 2015-08-20Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated13 enrolled